Targetable signaling pathway mutations and progression of IDH-mutant glioma.
Hiroaki Wakimoto
No relevant relationships to disclose
Shota Tanaka
No relevant relationships to disclose
William T. Curry
No relevant relationships to disclose
Franziska Loebel
No relevant relationships to disclose
Dan Zhao
No relevant relationships to disclose
Kensuke Tateishi
No relevant relationships to disclose
Juxiang Chen
No relevant relationships to disclose
Lindsay K. Klofas
No relevant relationships to disclose
Nina Lelic
No relevant relationships to disclose
James C. Kim
No relevant relationships to disclose
Dora Dias-Santagata
Consultant or Advisory Role - Bio-Reference Laboratories
Other Remuneration - Patent 20100286143
Leif W. Ellisen
Consultant or Advisory Role - Bio-Reference Laboratories
Other Remuneration - SNaPshot patent pending
Darrell R. Borger
Consultant or Advisory Role - Bio-Reference Laboratories
Sarah-Maria Fendt
No relevant relationships to disclose
Matthew Vander Heiden
Consultant or Advisory Role - Agios
Stock Ownership - Agios; Johnson & Johnson (I)
Honoraria - Boehringer Ingelheim
Tracy Batchelor
Consultant or Advisory Role - Advance Medical; Champions Biotechnology; Kirin Pharmaceuticals; Merck; Novartis; Proximagen; Roche
Honoraria - Educational Concepts Group; Imedex; Oakstone Medical Publishing; Research to Practice; Robert Michael Educational Institute LLC; UpToDate
Research Funding - AstraZeneca; Millennium; Pfizer
A. John Iafrate
Consultant or Advisory Role - Bio-Reference Laboratories
Other Remuneration - SNaPshot patent pending
Daniel P. Cahill
No relevant relationships to disclose
Andrew S. Chi
No relevant relationships to disclose